Search

Search Results

• 

  Possible interplay between interleukin-15 and interleukin-17 into the pathogenesis of idiopathic inflammatory myopathies

  A. Notarnicola, G. Lapadula, D. Natuzzi, F. Iannone

  215-223

  06-11-2014

  https://doi.org/10.4081/reumatismo.2014.746

  1836

  PDF: 1221
• 

  Acute heart failure and rhabdomyolysis: a clue for the diagnosis of polymyositis with cardiac involvement

  P. Pinto-Lopes, L. Carneiro-Leão, R. Morais, J. Pinheiro, A. Vieira Lopes, P. Bettencourt

  78-83

  03-08-2017

  https://doi.org/10.4081/reumatismo.2017.924

  2161

  PDF: 1004
• 

  Idiopathic inflammatory myopathies linked to vaccination against SARS-CoV-2: a systematic review

  A. Camargo-Coronel, H. Quiñones-Moya; M.R. Hernández-Zavala; J.R. Hernández-Vázquez, M.Á. Vázquez-Zaragoza

  08-05-2023

  https://doi.org/10.4081/reumatismo.2023.1548

  2003

  PDF: 1387
• 

  The use of rituximab in idiopathic inflammatory myopathies: description of a monocentric cohort and review of the literature

  S. Barsotti, E. Cioffi, A. Tripoli, A. Tavoni, A. d’Ascanio, M. Mosca, R. Neri

  78-84

  06-07-2018

  https://doi.org/10.4081/reumatismo.2018.1011

  2631

  PDF: 1395
• 

  Small molecules in idiopathic inflammatory myopathies: a systematic review and a multicenter case series about Janus kinase inhibitors and apremilast

  Chiara Rizzo, Silvia Grazzini, Edoardo Conticini, Hector Chinoy, Roberto D’Alessandro, Federica Camarda, Luca Cantarini, Bruno Frediani, Giuliana Guggino, Lidia La Barbera

  13-01-2025

  https://doi.org/10.4081/reumatismo.2025.1718

  1525

  PDF: 116

  SUPPLEMENTARY MATERIAL: 113
• 

  Diagnosis and treatment of interstitial lung disease related to systemic autoimmune myopathies: a narrative review

  F.H.C. De Souza, D.B. De Araújo, L.S. Hoff, B.G. Baldi, M.S.M.S. Faria, L.F da Rocha Junior, L.R.S Da Silva, G.L Behrens Pinto, M.C. Bezerra, R. Miossi, R.A. Cordeiro, S.K Shinjo

  08-05-2023

  https://doi.org/10.4081/reumatismo.2023.1571

  2154

  PDF: 1383
• 

  Real-life effectiveness of rituximab in different subsets of idiopathic inflammatory myopathies

  Stefano Stano, Fabio Cacciapaglia, Laura Coladonato, Giuseppe Lopalco, Florenzo Iannone, Marco Fornaro

  07-04-2025

  https://doi.org/10.4081/reumatismo.2025.1817

  1684

  PDF: 29

  SUPPLEMENTARY MATERIAL: 297
• 

  First report of anti-TIF1γ dermatomyositis in a patient with myelodysplastic syndrome

  B. Palterer, G. Vitiello, D. Cammelli

  75-77

  03-08-2017

  https://doi.org/10.4081/reumatismo.2017.923

  1645

  PDF: 885

• Long term functional outcome of idiopathic inflammatory myopathies

  R. Neri, M. Mosca, T. Grazzini, A. Tavoni, G. Pasero, S. Bombardieri

  40-45

  https://doi.org/10.4081/reumatismo.2001.40

  1088

  PDF: 1029

• Myositis specific and myositis associated autoantibodies in idiopathic inflammatory myopathies: a serologic study of 46 patients

  A. Ghirardello, S. Zampieri, L. Iaccarino, E. Tarricone, M. Tonello, R. Bendo, R. Rondinone, F. Cozzi, A. Doria

  22-28

  https://doi.org/10.4081/reumatismo.2005.22

  8045

  PDF: 31643
• 

  Patients with anti-small ubiquitin-like modifier activating enzyme-positive dermatomyositis resembling antisynthetase syndrome with poor prognosis: a bicentric international retrospective study and literature review

  Camila Gusmão Vicente de Carvalho, Barbara Bayeh, Fernando Henrique Carlos de Souza, Renata Miossi, Pleiades Tiharu Inaoka, Takashi Matsushita, Naoki Mugii, Samuel Katsuyuki Shinjo

  09-10-2024

  https://doi.org/10.4081/reumatismo.2024.1686

  2366

  PDF: 344
• 

  Tuberculosis infection in patients with dermatomyositis

  Luis Carlos Palomino Romero, Alfredo Vargas Caselles, Natalia Soledad Rius, Enrique Soriano, Javier Rosa, Marina Scolnik

  07-03-2025

  https://doi.org/10.4081/reumatismo.2025.1631

  926

  PDF: 126
• 

  Polymyositis following varicella and mumps infection in adults: report of two cases

  F. Masini, K. Gjeloshi, E. Pinotti, R. Ferrara, C. Romano, G. Cuomo

  19-12-2023

  https://doi.org/10.4081/reumatismo.2023.1562

  1264

  PDF: 420
• 

  COVID-19 as potential aggravating factor for the natural course of new onset-dermatomyositis

  M.S.M.S. Faria, S.K. Shinjo

  03-05-2022

  https://doi.org/10.4081/reumatismo.2022.1440

  2202

  PDF: 600

• Nasopharyngeal carcinoma and Dermatomyositis: a case report

  C. Botsios, P. Boscolo Rizzo, M.C. Da Mosto, P. Ostuni, P. Sfriso, S. Todesco, C. Marchiori

  48-51

  https://doi.org/10.4081/reumatismo.2002.48

  1561